Product Information
RIZATRIPTAN 10 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.4179 per EA under NDC 33342008872. Its NADAC has been published 532 times since Mar 11, 2015.
FDA first approved this application on Feb 11, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342008872
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA203147FDA Approved
2/11/2014
TE Code
AB
On Market Since
3/11/2014
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 10 MG TABLET has been published 532 times since Mar 11, 2015, and over the history we have for it it has declined 78.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4179 per EA |
|---|---|
| All-time high | $1.9321 (Mar 11, 2015) |
| All-time low | $0.3131 (May 22, 2024) |
| Median price | $0.6895 |
| Average price | $0.7527 |
| Largest weekly change | +30.1% (Feb 22, 2023) |
| Weeks tracked | 532 |
| Tracking since | Mar 11, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+24.7%
5Y
-29.3%
All
-78.4%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 10 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.4179 per EA (NDC 33342008872), effective May 14, 2025.
How has the price of RIZATRIPTAN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 10 MG TABLET has declined 78.4%. It has been tracked across 532 weekly CMS publications since Mar 11, 2015.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 10 MG TABLET?
Since Mar 11, 2015, the NADAC for RIZATRIPTAN 10 MG TABLET has ranged from a low of $0.3131 (May 22, 2024) to a high of $1.9321 (Mar 11, 2015), with a median of $0.6895 per EA.
Are there cheaper alternatives to RIZATRIPTAN 10 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 10 MG TABLET, is $0.3524 per EA — about 16% below RIZATRIPTAN 10 MG TABLET.
Who manufactures RIZATRIPTAN 10 MG TABLET?
RIZATRIPTAN 10 MG TABLET (NDC 33342008872) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.